A recent analysis raises urgent alarms that the UK-US pharma deal could result in nearly 230,000 preventable deaths in England. Critics caution that this agreement may limit access to affordable medicines, igniting major public health fears
A recent analysis raises urgent alarms that the UK-US pharma deal could result in nearly 230,000 preventable deaths in England. Critics caution that this agreement may limit access to affordable medicines, igniting major public health fears
